Observational Biologic or Prosthetic Mesh

NCT03317665 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2021-10-06

No results posted yet for this study

Summary

The purpose of this study is to assess the incidence of hernia recurrence with the use of biologic and prosthetic mesh in ventral hernia repair.

Conditions

  • Ventral Incisional Hernia

Interventions

DEVICE

Mesh for hernia repair

Permacol, Parietex, Progrip, Strattice Perforated, and Surgimend.

Sponsors & Collaborators

  • Integra LifeSciences Corporation

    collaborator INDUSTRY
  • University of South Florida

    lead OTHER

Principal Investigators

  • Vic Velanovich, MD · University of South Florida

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-11
Primary Completion
2021-06-11
Completion
2021-06-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03317665 on ClinicalTrials.gov